Haiyang Hu

5.3k total citations
170 papers, 4.4k citations indexed

About

Haiyang Hu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Haiyang Hu has authored 170 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 50 papers in Biomedical Engineering and 47 papers in Biomaterials. Recurrent topics in Haiyang Hu's work include RNA Interference and Gene Delivery (50 papers), Nanoparticle-Based Drug Delivery (46 papers) and Nanoplatforms for cancer theranostics (38 papers). Haiyang Hu is often cited by papers focused on RNA Interference and Gene Delivery (50 papers), Nanoparticle-Based Drug Delivery (46 papers) and Nanoplatforms for cancer theranostics (38 papers). Haiyang Hu collaborates with scholars based in China, United States and Japan. Haiyang Hu's co-authors include Dawei Chen, Mingxi Qiao, Xiuli Zhao, Jiulong Zhang, Xinlong Zang, Chunrong Yang, Menghao Shi, Wenpan Li, Jia Li and Yihui Deng and has published in prestigious journals such as ACS Nano, Applied Physics Letters and PLoS ONE.

In The Last Decade

Haiyang Hu

163 papers receiving 4.3k citations

Peers

Haiyang Hu
Jee‐Heon Jeong South Korea
Rebecca M. Haley United States
Marissa E. Wechsler United States
Hao Cheng United States
Jee‐Heon Jeong South Korea
Haiyang Hu
Citations per year, relative to Haiyang Hu Haiyang Hu (= 1×) peers Jee‐Heon Jeong

Countries citing papers authored by Haiyang Hu

Since Specialization
Citations

This map shows the geographic impact of Haiyang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyang Hu more than expected).

Fields of papers citing papers by Haiyang Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyang Hu. The network helps show where Haiyang Hu may publish in the future.

Co-authorship network of co-authors of Haiyang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyang Hu. A scholar is included among the top collaborators of Haiyang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyang Hu. Haiyang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Shuang, Guannan Guan, Ming Zhao, et al.. (2025). In Situ Remodeling of Tumor Microenvironment via Specific Cancer-Associated Fibroblasts Subtype Engineering to Boost Antitumor Immunity. ACS Nano. 19(43). 37815–37836.
2.
Wang, Qiang, et al.. (2024). Multidisciplinary design optimization of axisymmetric exhaust systems: Integrating aerodynamic performance and infrared stealth capabilities. International Journal of Thermal Sciences. 208. 109462–109462. 1 indexed citations
3.
Wang, Qi, et al.. (2024). Membrane Fusion Liposomes Deliver Antifibrotic and Chemotherapeutic Drugs Sequentially to Enhance Tumor Treatment Efficacy by Reshaping Tumor Microenvironment. Advanced Healthcare Materials. 13(20). e2400219–e2400219. 8 indexed citations
4.
Crosignani, Stefano, Sébastien Campos, Craig S. Harris, et al.. (2024). Discovery of a novel series of selective macrocyclic PKCTheta inhibitors. Bioorganic & Medicinal Chemistry Letters. 100. 129630–129630. 2 indexed citations
5.
Zhao, Ming, et al.. (2023). Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation. Journal of Controlled Release. 355. 211–227. 35 indexed citations
7.
Huang, Ziyuan, Yuying Chen, Jiulong Zhang, et al.. (2021). Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy. ACS Applied Materials & Interfaces. 13(33). 39934–39948. 41 indexed citations
8.
Jia, Nan, Jingjing Ma, Haiyang Hu, et al.. (2020). HA-Modified R8-Based Bola-Amphiphile Nanocomplexes for Effective Improvement of siRNA Delivery Efficiency. ACS Biomaterials Science & Engineering. 6(4). 2084–2093. 15 indexed citations
9.
Jia, Nan, Xirui Zhang, Wenpan Li, Dawei Chen, & Haiyang Hu. (2020). Phospholipid-Coated Guanosine Diphosphate Auxiliary CaP Active Nanoparticles Can Systematically Improve the Efficiency of Gene Therapy for Cancer Disease. ACS Biomaterials Science & Engineering. 6(4). 2107–2116. 4 indexed citations
10.
Fu, Jia, et al.. (2020). The Blood–Brain Barrier Cell-Targeted Gene Delivery System to Enhance Nerve Growth Factor Protein Secretion in the Brain. ACS Biomaterials Science & Engineering. 6(11). 6207–6216. 9 indexed citations
11.
Zhang, Xiaoxu, Xinlong Zang, Mingxi Qiao, et al.. (2020). Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy. ACS Biomaterials Science & Engineering. 6(10). 5675–5684. 15 indexed citations
12.
Zang, Xinlong, Xiaoxu Zhang, Haiyang Hu, et al.. (2019). Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy. Molecular Pharmaceutics. 16(5). 2249–2258. 76 indexed citations
13.
Chen, Kang, Xiu Xin, Lipeng Qiu, et al.. (2019). Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy. Acta Biomaterialia. 100. 118–131. 18 indexed citations
14.
Li, Jia, Qi Wang, Haiyang Hu, et al.. (2019). pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells. ACS Applied Materials & Interfaces. 11(18). 16296–16310. 89 indexed citations
15.
Li, Wenpan, Jia Fu, Dan Liu, et al.. (2019). Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency. Acta Biomaterialia. 96. 456–467. 26 indexed citations
16.
Zang, Xinlong, Xiaoxu Zhang, Xiuli Zhao, et al.. (2019). Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy. Molecular Pharmaceutics. 16(4). 1714–1722. 51 indexed citations
17.
Li, Chenxi, Yue Lü, Qing Chen, et al.. (2019). Tailored Polymers with Complement Activation Ability To Improve Antitumor Immunity. Molecular Pharmaceutics. 16(6). 2648–2660. 6 indexed citations
18.
19.
Zhang, Jie, Dan Liu, Mengjun Zhang, et al.. (2016). The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells. International Journal of Nanomedicine. Volume 11. 3677–3690. 57 indexed citations
20.
Hu, Haiyang, et al.. (2001). Dendrite and fractal patterns formed on the surface of bismuth-ion-implanted LiNbO3. Journal of Physics Condensed Matter. 13(26). 5893–5899. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026